Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nervorant 5G
- Development stage
- Unknown
- Lead developer
- Currant Life Science
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Nervorant 5G is a multi-ingredient nutritional supplement and branded generic formulation developed by Currant Life Science, primarily indicated for use within the CNS (Central Nervous System) therapeutic segment. The "5G" designation refers to a specific combination of five key botanical extracts: Ginseng, Ginkgo Biloba, Green Tea Extract, Grape Seed Extract, and Garlic Oil. This formulation is typically supplemented with Omega-3 fatty acids (including Eicosapentaenoic Acid and Docosahexaenoic Acid), as well as a comprehensive array of vitamins, minerals, and trace elements. Nervorant 5G is designed to provide neuroprotective, antioxidant, and anti-inflammatory support, making it suitable for managing neuropathic pain, cognitive impairment, and general nutritional deficiencies associated with neurological disorders. It is administered orally, typically in the form of softgel capsules.
- Brand names
- Nervorant 5GNervorant5GNervorant-5G
02
Targets
PTAFR (Platelet-activating factor receptor)FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on Nervorant 5G.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nervorant 5G.